10.1371/journal.pone.0126603.g001 Rongcai Yue Rongcai Yue Xia Li Xia Li Bingyang Chen Bingyang Chen Jing Zhao Jing Zhao Weiwei He Weiwei He Hu Yuan Hu Yuan Xing Yuan Xing Yuan Na Gao Na Gao Guozhen Wu Guozhen Wu Huizi Jin Huizi Jin Lei Shan Lei Shan Weidong Zhang Weidong Zhang Chemical structures of the four compounds, astragaloside IV (AGS-IV), 6-<i>O</i>-<i>β</i>-<i>D</i>-glucopyranosyl cycloastragenol (6-<i>O</i>-<i>β</i>-<i>D</i>-glu CAG), 3-<i>O</i>-<i>β</i>-<i>D</i>-xylopyranosyl cycloastragenol (3-<i>O</i>-<i>β</i>-<i>D</i>-xyl CAG), cycloastragenol (CAG). Public Library of Science 2015 PC 12 cells ppi Chinese Materia Medica neuroprotective effect protein mechanism Astragalus membranaceus Bunge iv proteomic 2015-05-11 03:09:41 Figure https://plos.figshare.com/articles/figure/_Chemical_structures_of_the_four_compounds_astragaloside_IV_AGS_IV_6_O_946_D_glucopyranosyl_cycloastragenol_6_O_946_D_glu_CAG_3_O_946_D_xylopyranosyl_cycloastragenol_3_O_946_D_xyl_CAG_cycloastragenol_CAG_/1410024 <p>Chemical structures of the four compounds, astragaloside IV (AGS-IV), 6-<i>O</i>-<i>β</i>-<i>D</i>-glucopyranosyl cycloastragenol (6-<i>O</i>-<i>β</i>-<i>D</i>-glu CAG), 3-<i>O</i>-<i>β</i>-<i>D</i>-xylopyranosyl cycloastragenol (3-<i>O</i>-<i>β</i>-<i>D</i>-xyl CAG), cycloastragenol (CAG).</p>